3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2
- 1 August 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 28 (7) , 739-749
Abstract
Past reports have shown that the sensitivity of cancer cells to TRAIL-induced apoptosis is related to their expression of TRAIL-death receptors on the cell surface. However, the level of TRAIL-death receptors expression on cancer cells is always low. Our previous research showed that nasopharyngeal carcinoma (NPC) cells have a poor sensitivity to low doses of TRAIL. Here, we evaluated combined treatment with the energy inhibitor 3-bromopyruvate (3BP) and TRAIL as a method to produce an increased apoptotic response in NPC cells. The results showed that 3BP and TRAIL together produced higher cytotoxicity and increased TRAIL-R2 expression in NPC cells compared with the effects of either 3BP or TRAIL alone. These findings led us to hypothesize that 3BP may sensitize NPC cells to TRAIL. 3BP is a metabolic blocker that inhibits hexokinase II activity, suppresses ATP production, and induces endoplasmic reticulum (ER) stress. Our results showed that 3BP also activated AMP-activated protein kinase, which we found to play an important role in the induction of ER stress by 3BP. Furthermore, the induction of TRAIL-R2 expression and the sensitization of the NPC cells to TRAIL by 3BP were reduced when we inhibited the expression of CHOP. Taken together, our results showed that a low dose of 3BP sensitized NPC cells to TRAIL-induced apoptosis by the upregulation of CHOP, which was mediated by the activation of AMP-activated protein kinase and ER stress. The results showed that 3BP is a promising candidate agent for enhancing the therapeutic response to TRAIL in NPC.Keywords
This publication has 31 references indexed in Scilit:
- A novel curcuminoid exhibits enhanced antitumor activity in nasopharyngeal carcinomaInternational Journal of Oncology, 2016
- Nasopharyngeal carcinomaThe Lancet, 2016
- Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cellsOncology Reports, 2015
- A formulated red ginseng extract upregulates CHOP and increases TRAIL-mediated cytotoxicity in human hepatocellular carcinoma cellsInternational Journal of Oncology, 2013
- 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2Molecular Cancer, 2009
- Arsenic Trioxide Sensitizes Human Glioma Cells, but not Normal Astrocytes, to TRAIL-Induced Apoptosis via CCAAT/Enhancer-Binding Protein Homologous Protein–Dependent DR5 Up-regulationCancer Research, 2008
- The cancer cell’s “power plants” as promising therapeutic targets: An overviewJournal of Bioenergetics and Biomembranes, 2007
- Receptor-Mediated Choreography of Life and DeathJournal of Clinical Immunology, 2003
- The National Cancer Data Base Report on Cancer of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 1998
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995